Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Orchiectomy.

O Alfthan

    Scandinavian Journal of Urology and Nephrology. Supplementum
    |January 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Orchiectomy, a treatment for prostate cancer, effectively reduces testosterone without feminizing side effects or cardiovascular risks. This surgical option offers significant advantages with minimal disadvantages for patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Prostatic tissue pressure measurement as a possible diagnostic procedure in patients with chronic nonbacterial prostatitis/chronic pelvic pain syndrome.

    Urological research·2000
    Same author

    Increased intraprostatic pressure in patients with chronic prostatitis.

    Urological research·1999
    Same author

    Current concepts in the role of intravesical instillations in the therapy and prophylaxis of superficial transitional-cell cancer of the bladder. The Finnbladder Research Group.

    World journal of urology·1997
    Same author

    Alternating mitomycin C and bacillus Calmette-Guerin instillation prophylaxis for recurrent papillary (stages Ta to T1) superficial bladder cancer. Finnbladder Group.

    The Journal of urology·1996
    Same author

    Cyclosporine in severe interstitial cystitis.

    The Journal of urology·1996
    Same author

    Alternating mitomycin C and bacillus Calmette-Guerin instillation therapy for carcinoma in situ of the bladder. The Finnbladder Group.

    The Journal of urology·1995
    Same journal

    The global burden of urinary bladder cancer.

    Scandinavian journal of urology and nephrology. Supplementum·2008
    Same journal

    Bladder cancer: chemoprevention, complementary approaches and budgetary considerations.

    Scandinavian journal of urology and nephrology. Supplementum·2008
    Same journal

    Screening for bladder cancer: theoretical and practical issues in considering the treated and untreated natural history of the various forms of the disease.

    Scandinavian journal of urology and nephrology. Supplementum·2008
    Same journal

    Combining a molecular profile with a clinical and pathological profile: biostatistical considerations.

    Scandinavian journal of urology and nephrology. Supplementum·2008
    Same journal

    How to combine the molecular profile with the clinicopathological profile of urothelial neoplastic lesions.

    Scandinavian journal of urology and nephrology. Supplementum·2008
    Same journal

    Gene signatures for risk-adapted treatment of bladder cancer.

    Scandinavian journal of urology and nephrology. Supplementum·2008
    See all related articles

    Area of Science:

    • Urology
    • Oncology
    • Endocrinology

    Background:

    • Prostate carcinoma is a significant health concern.
    • Hormonal therapy, including androgen deprivation, is a common treatment modality.
    • Testosterone plays a crucial role in prostate cancer progression.

    Purpose of the Study:

    • To discuss the advantages and disadvantages of orchiectomy as a primary treatment for prostate carcinoma.
    • To compare orchiectomy with other forms of androgen deprivation therapy.
    • To evaluate the efficacy and safety profile of orchiectomy.

    Main Methods:

    • Literature review and discussion of existing data on orchiectomy for prostate cancer.
    • Analysis of hormonal changes, side effects, and clinical outcomes associated with orchiectomy.

    Related Experiment Videos

  • Comparison of subcapsular versus total orchiectomy.

    • Main Results:

    • Orchiectomy effectively reduces plasma testosterone levels immediately.
    • It avoids the use of oestrogen hormones, thus preventing feminisation and cardiovascular complications.
    • Subcapsular orchiectomy appears to be as effective as total orchiectomy.
    • The disadvantages associated with orchiectomy are minimal.

    Conclusions:

    • Orchiectomy is a viable primary treatment option for prostate carcinoma with a favorable risk-benefit profile.
    • It offers an effective method of androgen deprivation without the adverse effects associated with estrogen therapy.
    • Further research may explore long-term outcomes and patient-reported quality of life.